No K576-100) The assay was performed according to manufacturer’

No. K576-100). The assay was performed according to manufacturer’s instructions for the colorimetric assay. Absorbance was read at 570nm using a spectrophotometer (NanoPhotometer, Implen) equipped with a quartz ultramicrocell (Hellma, VWR, Denmark). All readings

were corrected for nonspecific background by subtracting the zero value of phosphatidylcholine. The phosphatidylcholine concentration of each sample was calculated from the plotted standard curve, and from these values the total lipid concentration was estimated assuming that phosphatidylcholine comprises approximately 65mol% of the final liposome-concentration measured in molar amounts. The calculated protein concentration Inhibitors,research,lifescience,medical was then correlated to the lipid concentration with calculate the amount of antibodies/nmol liposome. 2.5. In Vitro Cellular Binding and Internalization

of Liposomes The cellular binding of liposomes to U87mg and U251mg cells was investigated in vitro to determine the uptake of targeted anti-EGFR liposomes compared to those of unconjugated and nonimmune-IgG conjugated liposomes. The two cell lines both Inhibitors,research,lifescience,medical express high levels of EGFR. However, U87mg was chosen for the in vivo studies because a successful U87mg intracranial xenograft model had already been established in our laboratory. The cellular uptake of green fluorescent liposomes was visualized by fluorescence microscopy, and their targeting potential was quantified by flow cytometric analysis. U87mg cells Inhibitors,research,lifescience,medical were seeded in separate 8 wells LabTek permanox chamber slides 24 hours before initiating the uptake experiments. The liposomes were added to the wells at a concentration of 75nM (0.0075mol/L) per 105 seeded Inhibitors,research,lifescience,medical cells and incubated for 2 hours at 37°C in cell medium supplemented with 10% (FCS) and 1% penicillin/streptomycin. Unbound liposomes were removed by washing 3 times with 0.1M PBS (pH 7.0). The cells were fixed in 4% paraformaldehyde for 15 minutes and nuclei stained with DAPI. In order to confirm that the primary anti-human-EGFR Inhibitors,research,lifescience,medical antibodies and www.selleckchem.com/screening/natural-product-library.html nonimmune IgG were indeed conjugated

to the liposomes, Alexa Fluor 488 goat-anti-mouse secondary antibody was incubated for 45 minutes with the cells after removal of unbound liposomes. Fluorescence images were obtained with an AxioCam MRm (Carl below Zeiss International) attached to a Zeiss Axio Observer.Z1 microscope (Carl Zeiss International) using the AxioVision rel. 4.7 software (Carl Zeiss International). For each cell line, a representative Z-stack of 25 stacks was obtained at 400x magnification. In order to eliminate light of different planes from the Z-stack, 3D deconvolution was carried out using AxioVision rel. 4.7 software (Carl Zeiss International). 3D deconvolution was performed using a theoretical point spread function with 25 iterations. Flow cytometry was used to quantify the targeting potential of the liposomes. Identical liposome concentrations and incubation times were applied during this experiment (75nmoles/105 cells).

Leave a Reply

Your email address will not be published. Required fields are marked *

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>